Pharmacogenomics
Development of a scalable pharmacogenomic clinical decision support service
Fusaro VA, et al. AMIA Summits Transl Sci Proc2013;2013:60
Fusaro VA, et al. AMIA Summits Transl Sci Proc2013;2013:60
Impact of CYP2C19 genetic testing on provider prescribing patterns for antiplatelet therapy after acute coronary syndromes and percutaneous coronary intervention.
Desai NR, Circ Cardiovasc Qual Outcomes. 2013 Nov 1;6(6):694-9.
Desai NR, Circ Cardiovasc Qual Outcomes. 2013 Nov 1;6(6):694-9.
Integrating pharmacogenetic information and clinical decision support into the electronic health record
Goldspiel BR, et al. J Am Med Inform Assoc 2013 Dec
Goldspiel BR, et al. J Am Med Inform Assoc 2013 Dec
Pharmacogenetics and coumarin dosing — recalibrating expectations
Zineh I, et al. N Engl J Med 2013; 369:2273-2275 2013 Dec 12
Zineh I, et al. N Engl J Med 2013; 369:2273-2275 2013 Dec 12
Providing pharmacogenomics clinical decision support using whole genome sequencing data as input
Huser V & Cimino JJ AMIA Summits Transl Sci Proc 2013;2013:81
Huser V & Cimino JJ AMIA Summits Transl Sci Proc 2013;2013:81
.png)
No hay comentarios:
Publicar un comentario